title: Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells.
abstract: Bronchogenic carcinomas arise from bronchial epithelial cells (BECs). Inhalation exposure of BECs to nitrosamines in cigarette smoke is an important exogenous risk factor for malignant transformation of BECs. Thus, an important endogenous risk factor is likely to be the capacity of BECs to metabolize nitrosamines. Among the cytochrome P450 enzymes capable of metabolizing nitrosamines, CYP2A6, CYP2E1 and CYP2B6 are expressed in BECs. In this study, we used quantitative RT-PCR to evaluate expression of CYP2A6 and CYP2E1 in primary human BECs from 12 non-smokers and eight smokers. CYP2A6 was expressed in 20/20 cases and quantifiable in 18/20 cases, with a mean level of 580 mRNA/10(6) beta-actin mRNA. CYP2E1 expression was observed in 9/20 cases, but in all cases it was expressed at levels below our limit of quantification (10 mRNA/10(6) beta-actin mRNA). There was significant (P < 0.05) 20-fold inter-individual variation in expression of CYP2A6. Further, the mean level of CYP2A6 among smokers (260 mRNA/10(6) beta-actin mRNA) was significantly lower than among non-smokers (740 mRNA/10(6) beta-actin mRNA). It is hypothesized that: (i) inter-individual variation in CYP2A6 gene expression may contribute to inter-individual variation in risk for bronchogenic carcinoma; (ii) smoking may reduce the level of expression of CYP2A6 in the BECs of some individuals; and (iii) CYP2A6 is more important than CYP2E1 for metabolic activation of nitrosamines in bronchial epithelial cells.
authors.affiliation: Department of Medicine, Medical College of Ohio, Toledo 43699-0008, USA.
authors.forename: E L
authors.initials: EL
authors.lastname: Crawford
authors.forename: D A
authors.initials: DA
authors.lastname: Weaver
authors.forename: J P
authors.initials: JP
authors.lastname: DeMuth
authors.forename: C M
authors.initials: CM
authors.lastname: Jackson
authors.forename: S A
authors.initials: SA
authors.lastname: Khuder
authors.forename: M W
authors.initials: MW
authors.lastname: Frampton
authors.forename: M J
authors.initials: MJ
authors.lastname: Utell
authors.forename: W G
authors.initials: WG
authors.lastname: Thilly
authors.forename: J C
authors.initials: JC
authors.lastname: Willey
mesh_terms: D000199:Actins / Q000235:genetics; D000328:Adult; D001189:Aryl Hydrocarbon Hydroxylases; D001483:Base Sequence; D001980:Bronchi / Q000166:cytology / Q000201:enzymology*; D065637:Cytochrome P-450 CYP2A6; D019392:Cytochrome P-450 CYP2E1 / Q000235:genetics*; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D017931:DNA Primers; D004847:Epithelial Cells / Q000201:enzymology; D005260:Female; D015870:Gene Expression; D006801:Humans; D008297:Male; D006899:Mixed Function Oxygenases / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D000199:Actins; D017931:DNA Primers; D012333:RNA, Messenger; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D019392:Cytochrome P-450 CYP2E1; D001189:Aryl Hydrocarbon Hydroxylases; C585710:CYP2A6 protein, human; D065637:Cytochrome P-450 CYP2A6